Heart Leaflet Technologies Overview

  • Founded
  • 2002
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

Heart Leaflet Technologies General Information


Operator of a clinical stage medical device company. The company develops medical device for the treatment of valvular heart disease and transcatheter aortic valve replacement technology.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Other Industries
Medical Supplies
Other Healthcare Technology Systems
The Bracco Group
Primary Office
  • 7351 Kirkwood Lane North
  • Suite 104
  • Maple Grove, MN 55369
  • United States
+1 (763) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Heart Leaflet Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 04-Apr-2010 000.00 Completed Generating Revenue
6. Later Stage VC 01-Jan-2008 000.00 000.00 Completed Generating Revenue
5. Convertible Debt 27-Jan-2007 00.000 00.000 Completed
4. Convertible Debt 13-Jun-2006 00.000 00.000 Completed
3. Early Stage VC (Series B) 11-Jan-2006 00000 00.000 Completed Generating Revenue
2. Early Stage VC 30-May-2004 $2.29M $3.35M Completed Product Development
1. Early Stage VC 30-May-2003 $1.06M $1.06M Completed Product Development
To view Heart Leaflet Technologies’s complete valuation and funding history, request access »

Heart Leaflet Technologies Executive Team (3)

Name Title Board Seat Contact Info
Kevin Bassett General Manager & Senior Vice President
Robert Wilson Founder & Chief Science Officer
You’re viewing 2 of 3 executive team members. Get the full list »

Heart Leaflet Technologies Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Olympus Business Creation America Corporate Venture Capital Minority 000 0000 000000 0
To view Heart Leaflet Technologies’s complete investors history, request access »